Waist Circumference Measurements in Schizophrenic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01243034
Recruitment Status : Unknown
Verified October 2010 by Changhua Christian Hospital.
Recruitment status was:  Not yet recruiting
First Posted : November 18, 2010
Last Update Posted : November 18, 2010
Information provided by:
Changhua Christian Hospital

Brief Summary:

The prevalence of metabolic syndrome(MS) among pt's with schizophrenia has been reported to be high, ranging from 24 to 43% in males and 27 to 52% in females. Schizophrenic patients with MS have an increased incidence of DM, coronary heart disease and increased mortality from cardiovascular diseases. Central adiposity is highly correlated with the presence of hypertension, coronary heart disease, type 2 diabetes, and increased mortality risk. Waist circumference(WC) is a better indicator of abdominal obesity and a better predictor of CVD than either BMI or waist-to-hip ratio. However, currently there is no standard location for the measurement of WC.

Objectives: 1. To compare the magnitude of WC measured at 3 sites ( immediately above the iliac crest, midpoint between the lowest rib and the iliac crest , umbilical level) in males and females.

2. To examine the correlation of WC with Triglyceride, cholesterol, HDL, LDL and glucose.

Condition or disease
Waist Circumference Measurements Schizophrenia Cardiovascular Risk Factor

Study Type : Observational
Estimated Enrollment : 80 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Variability of Waist Circumference Measurements at 3 Sites and Its Relationship With Cardiovascular Risk Factors in Patients With Schizophrenia
Study Start Date : November 2010
Estimated Primary Completion Date : September 2011
Estimated Study Completion Date : October 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
schizophrenia outpatients

Inclusion Criteria:

  • • Patients with schizophrenia or schizoaffective disorder (DSM-IV 295) age 18 till 65 years old.

    • Body weight change less than 1 kg in previous one month before index date.

Exclusion Criteria:

  • • Patients with a previous hyperlipidemia diagnosis or antilipemic prescription during the preceding 30 days.

    • Patients received any anti-hypertensives or oral hypoglycemic agents.
    • Pregnant or breast-feeding women.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01243034

Changhua Christian Hospital
Changhua, Taiwan, 500
Sponsors and Collaborators
Changhua Christian Hospital

Responsible Party: Cheng-Chen Chang, Changhua Christian Hospital Identifier: NCT01243034     History of Changes
Other Study ID Numbers: 100717
First Posted: November 18, 2010    Key Record Dates
Last Update Posted: November 18, 2010
Last Verified: October 2010

Additional relevant MeSH terms:
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders